Scholars@Duke publication: Development of XSCID gene therapy for posttransplant patients with persistent immune defects.

Development of XSCID gene therapy for posttransplant patients with persistent immune defects.

Publication , Conference

Puck, JM; Tsail, EJ; Levin, T; Kirby, MR; Hsu, AP; Seidel, NE; Porada, C; Zanjani, E; Bodine, DM; Malech, HL

Published in: BLOOD CELLS MOLECULES AND DISEASES

2002

BLOOD CELLS MOLECULES AND DISEASES

1079-9796

2002

343 / 343

APA

Chicago

ICMJE

MLA

NLM

Puck, J. M., Tsail, E. J., Levin, T., Kirby, M. R., Hsu, A. P., Seidel, N. E., … Malech, H. L. (2002). Development of XSCID gene therapy for posttransplant patients with persistent immune defects. In BLOOD CELLS MOLECULES AND DISEASES (Vol. 28, pp. 343–343).

Puck, J. M., E. J. Tsail, T. Levin, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. Porada, E. Zanjani, D. M. Bodine, and H. L. Malech. “Development of XSCID gene therapy for posttransplant patients with persistent immune defects.” In BLOOD CELLS MOLECULES AND DISEASES, 28:343–343, 2002.

Puck JM, Tsail EJ, Levin T, Kirby MR, Hsu AP, Seidel NE, et al. Development of XSCID gene therapy for posttransplant patients with persistent immune defects. In: BLOOD CELLS MOLECULES AND DISEASES. 2002. p. 343–343.

Puck, J. M., et al. “Development of XSCID gene therapy for posttransplant patients with persistent immune defects.” BLOOD CELLS MOLECULES AND DISEASES, vol. 28, no. 3, 2002, pp. 343–343.

Puck JM, Tsail EJ, Levin T, Kirby MR, Hsu AP, Seidel NE, Porada C, Zanjani E, Bodine DM, Malech HL. Development of XSCID gene therapy for posttransplant patients with persistent immune defects. BLOOD CELLS MOLECULES AND DISEASES. 2002. p. 343–343.

BLOOD CELLS MOLECULES AND DISEASES

1079-9796

2002

343 / 343